Jonathan Barratt

The Mayer Professor of Renal Medicine


I lead the Renal Research Group within the College of Life Sciences, University of Leicester. My research is focussed on a bench to bedside approach to improving our understanding of the pathogenesis of IgA nephropathy a common global cause of kidney failure. I am the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the International IgA Nephropathy Network. I work closely with pharmaceutical companies interested in new treatments for IgA nephropathy, and am Chief Investigator for a number of international randomised controlled Phase 2 and 3 clinical trials in IgA nephropathy. I was a member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group. I am an Editorial Board member for Kidney International and Clinical Journal of the American Society of Nephrology. I am a co-Chair of the UK Glomerulonephritis Clinical Study Group and was IgA nephropathy lead for the recent revision of the KDIGO Clinical Practice Guidelines for Glomerular Diseases.